-21.7%
MRNA vs RGEN
-37.7%
+16.0%
-93.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | RGEN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.8% | +6.5% | -11.3% | -8.4% |
| 7D | -20.9% | 0.0% | -20.9% | -21.1% |
| 30D | -13.3% | -2.1% | -11.1% | -12.3% |
| 3M | +212.6% | +3.9% | +208.6% | +210.8% |
| 6M | +309.0% | +65.7% | +243.3% | +224.2% |
| YTD | +567.3% | +5.4% | +561.9% | +548.4% |
| 1Y | +689.7% | +12.8% | +676.9% | +644.6% |
| 3Y | +157.4% | +14.7% | +142.8% | +123.5% |
| 5Y | -21.7% | -38.3% | +16.6% | +4.4% |
| All | -21.7% | -37.7% | +16.0% | +4.4% |
Cumulative growth
Daily Returns
Daily percentage return beside RGEN.
Daily Out/Under-Performance
Portfolio return minus RGEN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RGEN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded RGEN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling